" class="no-js "lang="en-US"> Jakub Zieliński - Medtech Alert
Wednesday, July 30, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Jakub Zieliński

Jakub Zieliński

About Jakub Zieliński

Jakub has over 20 years of experience in building and managing some of the largest online consumer brands.

He is a digital health specialist and a co-founder of many thematic websites. He is a frequent speaker at digital health conferences as well as an expert and mentor at the European Parliament.

Related Story

Companies

 European Healthtech Mindgram Closes €7 Million Seed Round and Begins Its European Expansion | Pharmtech Focus

European Healthtech Mindgram Closes €7 Million Seed Round and Begins Its European Expansion

April 5 2022

Mindgram, the European B2B platform providing integrated support for employees in the well-being sphere, has […]